CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations

CT radiomics to predict Deauville score 4 positive and negative Hodgkin lymphoma manifestations

Abstract 18F-FDG-PET/CT is standard to assess response in Hodgkin lymphoma by quantifying metabolic activity with the Deauville score. PET/CT, however, is time-consuming, cost-extensive, linked to high radiation and has a low availability. As an alternative, we investigated radiomics from non-contra...

Full description

Bibliographic Details
Main Authors:	Laura J. Jensen, Julian M. M. Rogasch, Damon Kim, Juliana Rießelmann, Christian Furth, Holger Amthauer, Bernd Hamm, Ingo G. Steffen, Thomas Elgeti, Sebastian N. Nagel
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-11-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-24227-0

Similar Items

Performance of Deauville Criteria in <sup>[18F]</sup>FDG-PET/CT Diagnostics of Giant Cell Arteritis
by: Jeffrey Siefert, et al.
Published: (2023-01-01)

Stability of Radiomic Features across Different Region of Interest Sizes—A CT and MR Phantom Study
by: Laura J. Jensen, et al.
Published: (2021-06-01)

Radiomics for Everyone: A New Tool Simplifies Creating Parametric Maps for the Visualization and Quantification of Radiomics Features
by: Damon Kim, et al.
Published: (2021-09-01)

Enhancing the stability of CT radiomics across different volume of interest sizes using parametric feature maps: a phantom study
by: Laura J. Jensen, et al.
Published: (2022-09-01)

Stability of Liver Radiomics across Different 3D ROI Sizes—An MRI In Vivo Study
by: Laura J. Jensen, et al.
Published: (2021-12-01)

Are Semiquantitative Methods Superior to Deauville Scoring in the Monitoring Therapy Response for Pediatric Hodgkin Lymphoma?
by: Firuz Ibrahim, et al.
Published: (2023-02-01)

The use of Deauville criteria in follow-up assessment of response to therapy in extra-nodal Non-Hodgkin's lymphoma
by: Manar Hussein Abdel-Sattar, et al.
Published: (2018-03-01)

Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning
by: Boris Gorodetski, et al.
Published: (2022-09-01)

Deauville score versus ratio Deauville score in the interpretation of interim 18F-FDG PET-CT and in prediction of outcome in children with FDG-avid extra-nodal lymphomas
by: Hadeer Yousef Elhamady, et al.
Published: (2022-10-01)

Sarcoid-Like Reaction in Non-Hodgkin’s Lymphoma—A Diagnostic Challenge for Deauville Scoring on <sup>18</sup>F-FDG PET/CT Imaging
by: Michael Winkelmann, et al.
Published: (2021-05-01)

Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin's Lymphoma.
by: Regine Kluge, et al.
Published: (2016-01-01)

FDG-PET Response Prediction in Pediatric Hodgkin’s Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value
by: Amr Elsayed M. Hussien, et al.
Published: (2015-01-01)

The effect of reduced scan time on response assessment FDG-PET/CT imaging using Deauville score in patients with lymphoma
by: Charlotte Hornnes, et al.
Published: (2021-01-01)

Risk Stratification Of Diffuse Large B-Cell Lymphoma With Interim PET/CT By Combining Deauville Scores And International Prognostic Index
by: Sun H, et al.
Published: (2019-11-01)

Methodological framework for radiomics applications in Hodgkin’s lymphoma
by: Martina Sollini, et al.
Published: (2020-06-01)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
by: Claudia Ortega, et al.
Published: (2023-03-01)

Impact of Reduced Image Noise on Deauville Scores in Patients with Lymphoma Scanned on a Long-Axial Field-of-View PET/CT-Scanner
by: Kirsten Korsholm, et al.
Published: (2023-03-01)

The role of parametric feature maps to correct different volume of interest sizes: an in vivo liver MRI study
by: Laura Jacqueline Jensen, et al.
Published: (2023-09-01)

MRI versus CT and PET/CT in the Preoperative Assessment of Hodgkin and Non-Hodgkin Lymphomas
by: Francesca Maccioni, et al.
Published: (2021-10-01)

Optimization of SPECT-CT Hybrid Imaging Using Iterative Image Reconstruction for Low-Dose CT: A Phantom Study.
by: Oliver S Grosser, et al.
Published: (2015-01-01)

Value of 18F-FDG PET/CT Parameters and Deauville 5-point Scoring in Efficacy Evaluation and Prognosis Prediction of Diffuse Large B Cell Lymphoma Patients
by: YANG Ming, et al.
Published: (2020-08-01)

The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations
by: John Ly, et al.
Published: (2019-07-01)

Hepatic Hodgkin lymphoma with delayed enhancement on CT and MRI
by: Yukie Higuma, MD, et al.
Published: (2017-03-01)

Baseline <sup>18</sup>F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
by: Elizabeth Katherine Anna Triumbari, et al.
Published: (2023-04-01)

Alopecia Areata and Demyelination as Paraneoplastic Manifestation in Paediatric Hodgkin's Lymphoma
by: Shravan Kanaparthi, et al.
Published: (2018-04-01)

Pachymeningeal Involvement with Blindness as the Presenting Manifestation of Non-Hodgkin Lymphoma
by: Charanpreet Singh, et al.
Published: (2018-02-01)

Cervical radiculopathy as the inaugural manifestation of non-hodgkin's lymphoma of rib
by: Monika Puranik, et al.
Published: (2021-01-01)

Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma
by: Özgür Ömür, et al.
Published: (2014-03-01)

Asphericity of tumor FDG uptake in non-small cell lung cancer: reproducibility and implications for harmonization in multicenter studies
by: Julian M. M. Rogasch, et al.
Published: (2020-11-01)

Diagnostic Value of FDG PET-CT Quantitative Parameters and Deauville-Like 5 Point-Scale in Predicting Malignancy of Focal Thyroid Incidentaloma
by: Philippe Thuillier, et al.
Published: (2019-02-01)

Reconstructed spatial resolution and contrast recovery with Bayesian penalized likelihood reconstruction (Q.Clear) for FDG-PET compared to time-of-flight (TOF) with point spread function (PSF)
by: Julian M. Rogasch, et al.
Published: (2020-01-01)

Unusual Manifestations of Vincristine Neuropathy: Report of Two Cases of Hodgkin Lymphoma
by: Olga Meltem Akay, et al.
Published: (2014-08-01)

Bilateral mydriasis as first manifestation of Hodgkin’s lymphoma: a case report
by: Enayatullah Baki, et al.
Published: (2022-12-01)

Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin’s Lymphoma
by: Akram Al-Ibraheem, et al.
Published: (2022-10-01)

The Role of PET/CT to Detect Bone Marrow Involvement in Hodgkin Lymphoma
by: Ali ESER, et al.
Published: (2019-04-01)

The predictive role of interim pet-ct in the treatment of hodgkin's lymphoma in children
by: N S Kulichkina, et al.
Published: (2017-09-01)

Prolonged lymphocytosis as the first manifestation of Hodgkin-like adult T-cell leukemia/lymphoma
by: Achiléa L. Bittencourt, et al.
Published: (2017-01-01)

Recalcitrant Pruritus as Primary Manifestation of Synchronous Hodgkins Lymphoma and Langerhans Cell Histiocytosis
by: Afsha A. Topal, et al.
Published: (2012-01-01)

FDG-PET/CT for the Management of Post-Chemotherapy Residual Mass in Hodgkin lymphoma
by: Andrea Gallamini, et al.
Published: (2021-08-01)

Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients
by: Sebastian Zschaeck, et al.
Published: (2022-04-01)